Comments
Lundbeck says Alzheimer's drug effective in trial
30.05.2012. | COPENHAGEN (Reuters) - Danish drugmaker Lundbeck said patients who took its Alzheimer's drug candidate Lu AE58054 in a phase 2 clinical trial achieved statistically significant improvement in cognitive performance when the compound was added to donepezil....
